Established in 2000, MitoDiag brings together French laboratories involved in the diagnosis of mitochondrial diseases. Through collaboration and knowledge sharing, the network aims to improve diagnostic practices and patient care by promoting expertise in mitochondrial disorders and their associated genetic abnormalities.
HISTORY
2000: Establishment of the network under the initiative of Joël LUNARDI, Anne LOMBES and Jean-Pierre MAZAT (AFM–INSERM).
2018: Creation of the MitoDiag name and logo.
2019: Development of the MitoMatcher database.
2021: Implementation and hosting of the MitoMatcher database on a secure LAMP server.
2022: Planning for the opening of the MitoMatcher query interface to all MitoDiag members, subject to data-sharing authorization from the French Data Protection Authority (CNIL)
SUCCESSIVE COORDINATORS :
Anne LOMBES (2001-2003)
Pascal REYNIER (2003-2012)
Vincent PROCACCIO (2012-Today) & Cecile Rouzier (2023-Today)
COMPOSITION
MitoDiag brings together approximately 60 members, including:
Medical biologists
Molecular geneticists and clinicians
Researchers
Patient associations (AMMi, OLY and AFM)
The network includes 11 diagnostic laboratories, ensuring nationwide coverage across France:
Angers, Bordeaux, Caen, Grenoble, Lille, Lyon, Nice, Paris (Necker, Bicêtre and Pitié-Salpêtrière) and Reims.
OBJECTIVES AND ACTIVITIES
Foster collaboration between laboratories involved in the diagnosis of mitochondrial diseases.
Strengthen clinical–biological interactions and multidisciplinary collaboration.
Organize regular meetings and conference calls to facilitate communication and knowledge exchange.
Promote quality assurance and harmonization of diagnostic practices.
Develop and maintain shared databases and resources.
Monitor scientific and technological advances and promote the implementation of diagnostic innovations (NGS, standardization of mitochondrial enzymatic activity assays, BN-PAGE, etc.).
Strengthen the links between diagnostic activities and basic and clinical research, in coordination with the Rare Disease Reference Centres.
Promote training and knowledge dissemination within the network.
Encourage collaboration between healthcare professionals, researchers and patient associations involved in mitochondrial diseases.